UCB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.6 EUR | +0.52% |
|
-1.67% | +61.13% |
| 04-11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
| 04-11 | UCB : Berenberg, Buy, raises its price target | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 26.47B | ||||||
| 89.87B | ||||||
| 37.57B | ||||||
| 14.25B | ||||||
| 12.99B | ||||||
| 11.93B |
- Stock Market
- Equities
- UCB Stock
- UNC Stock
- Charts UCB
- Sector Chart
